Ken Frazier on His Career Path, Social Justice, and Making a Difference
June 21, 2022
Lasker Lessons in Leadership featured an interview with Ken Frazier, Executive Chairman of the Board and Former CEO of Merck & Co.
June 2022 Newsletter
June 14, 2022
Read about the Lasker Public Service Awards, listen to our podcast Classic Lasker featuring William Foege, and view short videos from our new series Ask a Scientist.
Bringing Research Benefits to the World
June 14, 2022
Read about the people and organizations honored with the Lasker Public Service Award for bringing the fruits of medical research to the public.
Classic Lasker: William Foege
June 14, 2022
William Foege helped eradicate smallpox, served as the CDC director, and trained young public health professionals. Listen as Foege shares the trials and triumphs of his career.
In Memoriam: John Edward Porter
JUNE 8, 2022
John Edward Porter, whose legislative efforts to increase support for medical research was recognized with a Lasker Award has passed away at 87.
In Memoriam: Anne B. Fordyce
JUNE 4, 2022
Anne B. Fordyce, a longtime member of the Lasker Board of Directors, has passed away at 77.
May 2022 Newsletter
May 10, 2022
Read about Marc Feldmann's contributions to the fight against rheumatoid arthritis, watch Katalin Karikó discuss the development of mRNA therapies, and listen to the third episode of our podcast Classic Lasker, featuring Ralph Steinman.
Marc Feldmann: Teaming Up to Take on Rheumatoid Arthritis
May, 10 2022
Meet Marc Feldmann who established the brilliant use of the immune system’s own defenses to treat an autoimmune disease.
Classic Lasker: Ralph Steinman
May 10, 2022
Ralph Steinman eloquently explains the role of dendritic cells and what it felt like to receive the Lasker award.
Katalin Karikó: Developing mRNA for Therapy
MAY 5, 2022
In the 2022 Lasker-APSA Lecture, Katalin Karikó traces the history of messenger RNA, from its discovery in the early 1960s, through the modifications that enabled it to be used to rapidly deploy effective Covid-19 vaccines, and then looks forward toward the development of new mRNA therapies.
